Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dusseldorf - Delayed Quote EUR

ACADIA Pharmaceuticals Inc (DR6.DU)

12.65
+0.34
+(2.80%)
As of 9:31:23 AM GMT+2. Market Open.
Loading Chart for DR6.DU
  • Previous Close 12.31
  • Open 12.68
  • Bid 12.68 x --
  • Ask 12.88 x --
  • Day's Range 12.65 - 12.68
  • 52 Week Range 12.11 - 19.51
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: DR6.DU

View More

Performance Overview: DR6.DU

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DR6.DU
21.16%
S&P 500 (^GSPC)
10.10%

1-Year Return

DR6.DU
18.75%
S&P 500 (^GSPC)
4.28%

3-Year Return

DR6.DU
34.28%
S&P 500 (^GSPC)
23.78%

5-Year Return

DR6.DU
71.98%
S&P 500 (^GSPC)
89.00%

Compare To: DR6.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DR6.DU

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    2.08B

  • Enterprise Value

    1.47B

  • Trailing P/E

    10.41

  • Forward P/E

    41.49

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.46

  • Price/Book (mrq)

    3.22

  • Enterprise Value/Revenue

    1.76

  • Enterprise Value/EBITDA

    16.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DR6.DU

View More

Company Insights: DR6.DU

Research Reports: DR6.DU

View More